Synthesis and Initial Results for MAO-B Inhibition by New N-Propargyl-3-pyrrol-1-ylindanamine Derivatives, Analogues of Rasagiline-Reference-Cited by-同舟云学术

Synthesis and Initial Results for MAO-B Inhibition by New N-Propargyl-3-pyrrol-1-ylindanamine Derivatives, Analogues of Rasagiline

Published:2003-04-01 Issue:2 Volume:18 Page:147-153
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Guillon Jean¹,Hébert Guillaume²,Dallemagne Patrick³,Léger Jean-Michel¹,Vidaillac Céline¹,Thé Corinne¹,Lisowski Vincent³,Rault Sylvain³,Demotes-Mainard Jacques²,Jarry Christian¹

Affiliation:

1. EA—Pharmacochimie, UFR des Sciences Pharmaceutiques, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France

2. INSERM, Neurobiologie Intégrative, Institut François Magendie, Université Victor Segalen Bordeaux 2, rue Camille Saint-Saens, 33077, Bordeaux Cedex, France

3. Centre d'Etudes et de Recherche sur le Médicament de Normandie, UFR des Sciences Pharmaceutiques, 1 rue Vaubénard, 14032, Caen Cedex, France

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/1475636032000069800

Reference23 articles.

1. Zagnoli, F. and Rouhart, F. (2000) Maladie de Parkinson (Dion; Paris).

2. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification;European Journal of Medicinal Chemistry;2022-07

2. Aminothiaindanone as an Accessible Scaffold for a Three-Point Chemical Diversity;Synthesis;2021-06-04

3. Cyclic cis-1,3-Diamines Derived from Bicyclic Hydrazines: Synthesis and Applications;Synlett;2020-10-19

4. TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases;Bioorganic & Medicinal Chemistry;2013-04

5. Using entropy of drug and protein graphs to predict FDA drug-target network: Theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica;European Journal of Medicinal Chemistry;2011-04